MBL Wealth’s Colgate-Palmolive CL Stock Holding History

MBL Wealth’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$351K	Buy	4,119 +1,901	+86%	+$172K	0.02%	415
2026 Q2	$203K	Buy	+2,218	New	+$194K	0.01%	375

Other funds holding CL

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

MBL Wealth's CL Position: Q3 2026 in Review

MBL Wealth increased its Colgate-Palmolive (CL) stake by 86% in Q3 2026, buying an estimated $172K and bringing the position to 4,119 shares worth $351K. The position accounts for 0.02% of the portfolio, ranked #415.

MBL Wealth first reported a position in CL in Q2 2026 and has held it in 2 quarters since. 1,610 funds tracked by Wall St. Rank hold CL as of Q3 2026.

MBL Wealth held 4,119 shares of Colgate-Palmolive worth $351K as of Q3 2026.
MBL Wealth bought 1,901 Colgate-Palmolive shares in Q3 2026, an estimated $172K.
Colgate-Palmolive made up 0.02% of MBL Wealth's portfolio in Q3 2026, its #415 holding.
MBL Wealth first reported a position in Colgate-Palmolive in Q2 2026 and has held it in 2 quarters since.
1,610 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on MBL Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.